Added to YB: 2024-02-06
Pitch date: 2024-02-06
ACRS:US [bullish]
Aclaris Therapeutics, Inc.
+390.18%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Aclaris Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering and developing novel molecule product candidates for immuno-inflammatory diseases in the United States.
Market Cap
$776.5M
Pitch Price
$1.12
Price Target
N/A
Dividend
N/A
EV/EBITDA
-7.56
P/E
-9.91
EV/Sales
70.24
Sector
Pharmaceuticals
Category
N/A
Show full summary:
Aclaris Therapeutics, Inc. ACRS:US
A summary for this pitch has not been created yet.
Read full article (0 min)